Barely Significant
← all excerpts

IN.PACT™ Admiral™ drug-coated balloons in peripheral artery disease: current perspectives.

Med Devices (Auckl) · 2019 · PMC6385763 · PMID 30858737

Europe PMCDOI
1
hedged sentence
0.0500
closest p · 1.0× alpha
0.0500
boldest claim

The sentences

of borderline significanceP =0.05actually significant
Although the primary patency was significantly higher at 2 years, as presented by Rosenfield et al at SVS 2015, the statistical difference was of borderline significance (58.6% vs 53.0%, respectively, P =0.05). 67 Two-year follow-up data are also available for the other two CE-marked DCBs, Stellarex (presented at LINC 2018) and SeQuent Please. 45 In the ILLUMINATE EU RCT study, Stellarex demonstrated significantly greater freedom from CD-TLR compared with BA arm (Stellarex DCB vs BA: 88.9% vs 71.8%, P <0.001).

also in 2,624 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.